Skip to Content
Søk Menu

Dansk studie viser forbedret PFS og OS hos pasienter med metastatisk kolorektalkreft 

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

ESMO24: Immunotherapy Plus Chemotherapy Improves Progression-Free Survival in Metastatic Anal Cancer

/ Jan Andreasen
ESMO24Kolorektal kreft
Thierry André

Nivolumab plus Ipilimumab – A Potential New Standard-of-Care Treatment Option for Patients with MSI-H/dMMR Advanced Metastatic Colorectal Cancer

/ Thierry André
ASCOGI24Kolorektal kreft Play the Video 3:48
Nicole Serapin

The Impact of COVID-19 on the Stage at Presentation for Colorectal Cancer Patients

/ Nicole Serapin
ASCOGI24Kolorektal kreft Play the Video 7:11

ASCO GI 2024: ctDNA Status Post-Surgery is a Significant Predictor of Survival in Patients Following Surgery for Colorectal Cancer

/ Sofie Pohl
ASCOGI24Kolorektal kreft
Stacey Cohen

No significant impact of plasma cfDNA levels on ctDNA detection rates across different MRD in patients with colorectal cancer

/ Stacey Cohen
ASCOGI23Kolorektal kreft Play the Video 6:59
Josep Tabernero

New treatment option for refractory metastatic colorectal cancer – trifluridine/tipiracil plus bevacizumab

/ Josep Tabernero
ASCOGI23Kolorektal kreft Play the Video 10:04
Jeanne Tie

The randomized DYNAMIC Trial: ctDNA-guided approach towards adjuvant chemotherapy

/ Jeanne Tie
ASCO22Kolorektal kreft Play the Video 8:00
Jared Weiss

Promising clinical results for heavily pretreated patients with colorectal cancer

/ Jared Weiss
ESMO21Kolorektal kreft Play the Video 5:32

Nye europeiske retningslinjer for endorektal ultralydskanning

/ Søren R. Rafaelsen
Kolorektal kreftKreft
Back to top